Furthermore, glycan-binding proteins such as galectins, including galectin-2, -3, -4, and -8, have been identified at elevated levels in the serum of CRC patients, with galectin-2 demonstrating a positive association with high CRC mortality [164, 165]. This evidence concerns the gene LGALS2 and colorectal carcinoma.